PMID: 11911988Mar 26, 2002Paper

The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans

Neuroscience Letters
R HilkerWolf Dieter Heiss

Abstract

Autosomal recessive parkinsonism associated with mutations in the parkin gene represents a monogenic form of hereditary parkinsonism. We performed [(18)F]6-fluorodopa (FDOPA) positron emission tomography as a measurement of the nigrostriatal dopaminergic system as well as extensive haplotype analysis of the PARK 2 gene locus in 14 subjects with parkin mutations. In parkin subjects, the reduction of striatal FDOPA uptake increased with the number of mutated alleles and was also slightly obvious in asymptomatic parkin gene carriers in the heterozygous state. The abnormal FDOPA uptake pattern in parkin patients did not significantly differ from that of sporadic Parkinson's disease. Our data are in agreement with an enzymatic dysfunction of the gene's translational product, which has been shown to promote protein degradation as an ubiquitin-protein ligase. Thus, parkinsonism in parkin gene carriers may be related to abnormal nigral protein accumulation in the presence of a suprathreshold enzyme dysfunction.

References

Oct 1, 1991·Brain : a Journal of Neurology·J M Fearnley, A J Lees
Dec 1, 1990·Annals of Neurology·G V SawleR S Frackowiak
Dec 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C S Patlak, R G Blasberg
Jan 1, 1994·Journal of Computer Assisted Tomography·K WienhardW D Heiss
Sep 1, 1993·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D EidelbergS Fahn
May 29, 2000·The New England Journal of Medicine·C B LückingUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Nov 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangT M Dawson

❮ Previous
Next ❯

Citations

Dec 6, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Andreas H JacobsPedro Lowenstein
Jul 8, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ji-feng GuoBei-sha Tang
Apr 3, 2008·Nature Clinical Practice. Neurology·David J Brooks
Oct 18, 2005·Nature Medicine·Matthew J LaVoieDennis J Selkoe
Mar 29, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M C ShihR A Bressan
Aug 2, 2003·Annals of Neurology·Ebba LohmannUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Jun 16, 2009·Behavioural Brain Research·Susanne NikolausHans-Wilhelm Müller
Sep 2, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Susanne A SchneiderKailash P Bhatia
Oct 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Kathrin ReetzFerdinand Binkofski
Feb 3, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Susanne A SchneiderJohn Hardy
Jan 30, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Ebba LohmannUNKNOWN French Parkinson's Disease Genetics study group
Feb 26, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Yi ZhangHong-Mei Sun
Nov 14, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Madeleine E SharpKaren S Marder
Mar 18, 2004·Neuroimaging Clinics of North America·Monique ErnstSandra Jazbec
Sep 17, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Paul J LockhartMatthew J Farrer
Sep 22, 2007·Journal of Neurochemistry·Matthew J LaVoieMichael G Schlossmacher
Nov 11, 2008·Biochimica Et Biophysica Acta·Nicola Pavese, David J Brooks
Dec 25, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·W-D Heiss, R Hilker
Jul 22, 2004·American Journal of Medical Genetics. Part a·P PoorkajHaydeh Payami
Sep 7, 2004·Annals of Neurology·Enza Maria ValenteAnna Rita Bentivoglio
Jun 20, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Louis C TanJ William Langston
Sep 1, 2005·Annals of Neurology·Peter P PramstallerChristine Klein
Oct 21, 2011·Physiological Reviews·Olga CortiAlexis Brice
Jun 18, 2017·Journal of Neural Transmission·Nobutaka Hattori, Yoshikuni Mizuno
Sep 16, 2003·The Journal of Biological Chemistry·Aaron C PawlykVirginia M-Y Lee
May 6, 2003·Annals of Neurology·Sofia A OliveiraJeffery M Vance
Nov 26, 2010·Expert Review of Neurotherapeutics·Kumar M Prakash, Eng-King Tan
Jul 21, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Maria-João RibeiroUNKNOWN French Parkinson's Disease Genetics Study Group
Mar 31, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·David J Brooks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.